dedicated to the treatment of fertility problems
Preimplantation Genetic Diagnosis (PGD) is used to identify embryos at risk of a specific monogenic disorder or chromosomal disorder. It reduces the risk of passing on inherited disease by carriers or suffers of a known genetic condition. Unaffected embryos can then be selected for transfer free from that particular genetic defect.

Preimplantation Genetic Screening (PGS) uses next generation sequencing (NGS) / array comparative genomic hybridization (aCGH) technology to assess the number of chromosomes of the embryo and determine any gain or loss of the chromosome complements. Only chromosomally normal embryo will be transferred thus increases the chance of healthy pregnancy.

Day 5/6 blastocyst biopsy
Blastocyst Culture and Transfer
Day 3 embryo biopsy
Blastocyst Culture and Transfer

PGD indications :
• carrier of a monogenic disease
• carrier of a balanced chromosomal translocation

PGS indications :
• Advanced maternal age
• Recurrent miscarriage
• Repeated implantation failure
• Previous repeated abnormal pregnancies
• Severe male factor infertility

Assisted HatchingFertility Preservation